Daniel Courchesne
Directeur/Membre du Conseil chez F3 Platform Biologics, Inc.
Profil
Daniel Courchesne is currently the Director at F3 Platform Biologics, Inc. He previously worked as a Principal at Royal Bank of Canada and National Bank of Canada.
He also held positions as President at Global One Financial, Inc. and Senior Vice President at Entaire Global Cos., Inc. Courchesne received his undergraduate degree from the University of Sherbrooke in 1987.
Postes actifs de Daniel Courchesne
| Sociétés | Poste | Début |
|---|---|---|
F3 Platform Biologics, Inc.
 F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Directeur/Membre du Conseil | 04/10/2019 |
Anciens postes connus de Daniel Courchesne
| Sociétés | Poste | Fin |
|---|---|---|
| Global One Financial, Inc. | President | - |
| ROYAL BANK OF CANADA | Corporate Officer/Principal | - |
| NATIONAL BANK OF CANADA | Corporate Officer/Principal | - |
Entaire Global Cos., Inc.
 Entaire Global Cos., Inc. Finance/Rental/LeasingFinance Entaire Global Cos., Inc. provided funding and financing solutions. Its services included asset based lending, financial strategies, and solutions. The company was founded by Jonathan Rosen and William R. Muirhead in 2001 and was headquartered in Atlanta, GA. | Corporate Officer/Principal | - |
Formation de Daniel Courchesne
| University of Sherbrooke | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ROYAL BANK OF CANADA | Finance |
| NATIONAL BANK OF CANADA | Finance |
| Entreprise privées | 3 |
|---|---|
| Global One Financial, Inc. | |
Entaire Global Cos., Inc.
Entaire Global Cos., Inc. Finance/Rental/LeasingFinance Entaire Global Cos., Inc. provided funding and financing solutions. Its services included asset based lending, financial strategies, and solutions. The company was founded by Jonathan Rosen and William R. Muirhead in 2001 and was headquartered in Atlanta, GA. | Finance |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Health Technology |
